For the Inventor, By the Inventor

Enter inventor name

Gyeonggi-do, South Korea

Jue-Yeon Lee

USPTO Granted Patents = 23 (Patent Applications = 19)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 22 (Patent Applications = 42)

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 42(Granted Patents)

Location History:

Gwacheon, KR (2013)
Gyeonggi-do, KR (2013 - 2023)

Company Filing History:

Nano Intelligent Biomedical Engineering Corporation Co. Ltd.

15 out of 1,566

Seoul National University

Nibec Co., Ltd.

Nano Intelligent Biomedical Engineering Corporation

Chungbuk National University Industry-Academic Cooperation Foundation

6. 1 out of 549

Snu Rdb Foundation

where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...

Loading Chart...

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12161518 - Composition for treating and preventing gingivoperiodontitis or peri-implantitis, and interdental brush coated with same (2024-12-10),

2. 11760792 - GRP78-derived peptide for identifying high-efficiency stem cells (2023-09-19),

3. 11384120 - Peptide capable of binding to biomarker for inflammatory and metabolic diseases, and use thereof (2022-07-12),

4. 11365218 - Bifunctional peptide having capability to reduce inflammation and capability to facilitate differentiation of stem cells into chondrocytes and use thereof (2022-06-21),

5. 11179445 - Pharmaceutical composition and biomaterial comprising fusion peptide in which bone tissue-selective peptide bound to parathyroid hormone (PTH) or fragment thereof (2021-11-23),

6. 10836795 - Dual functional novel peptide having cell permeability and bone tissue regeneration ability, and use thereof (2020-11-17),

7. 10821065 - Peptide for inhibiting biofilms (2020-11-03),

8. 10815312 - Bifunctional peptide having capability to permeate cells and capability to regenerate muscles and use thereof (2020-10-27),

9. 10406264 - Peptide having titanium-binding ability (2019-09-10),

10. 10232083 - Mimetic tissue structure containing extracellular matrix protein-bone mineral complex and method for manufacturing same (2019-03-19),

11. 10155022 - Fat accumulation inhibitory peptide and pharmaceutical composition for preventing or treating obesity containing the same (2018-12-18),

12. 10066212 - Method for preparing induced pluripotent stem cells using synthetic peptide (2018-09-04),

13. 9993519 - Anticancer peptide for inhibiting proliferation of cancer stem cells and use thereof (2018-06-12),

14. 9801973 - Peptide having zirconia-binding capacity (2017-10-31),

15. 9644185 - Cell permeable fusion protein for facilitating reprogramming induction and use thereof (2017-05-09),

Title: The Innovative Journey of Inventor Jue-Yeon Lee

Introduction: Jue-Yeon Lee, a talented male inventor hailing from Gyeonggi-do, South Korea, has made significant contributions to the field of innovation with his creative mind and dedication to progress.

Latest Patents: Jue-Yeon Lee's latest patents showcase his commitment to pushing boundaries in technology and design, with a focus on improving everyday life through his inventions.

Career Highlights: Throughout his illustrious career, Jue-Yeon Lee has consistently demonstrated his prowess in inventing groundbreaking solutions. His work has not only garnered recognition but has also positively impacted various industries.

Collaborations: Jue-Yeon Lee's collaborative efforts with leading companies, research institutions, and universities have been instrumental in bringing his innovative ideas to life. These partnerships have further solidified his position as a respected inventor in the global innovation landscape.

Conclusion: In conclusion, Jue-Yeon Lee's journey as an inventor exemplifies a relentless pursuit of excellence and a passion for creating a better future through innovation. His remarkable achievements continue to inspire aspiring inventors worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…